Frog: I can't help with the Kondragunta litigation. Hopefully someone else will have some input.
In regards to the PRs, I would respectfully disagree with your comment: "it has not added to the knowledge base of the investors". Just the opposite is true IMO. Many current investors probably aren't aware of all the inner workings of the DNAP story as we are. Plus, a formal PR commits the info to history to be referenced by future potential DNAP investors during their DD. It's quite appropriate and necessary as the company evolves to tell their story as they see it and document it as well. Kudos to them!!!
The PR on the 2.5 upgrade was late in coming IMO. But none the less, it's marketing 101 to announce product upgrades such as this. IMO, I would not order the 2.0 version knowing that 2.5 provides 104 more markers (146% more). Who wouldn't pay the extra $61 to "allow for more sensitive and accurate determinations of low levels of admixture (such as that which may have been contributed by a single great grandparent). The enhanced sensitivity and efficiency allowed DNAPrint(TM) to also upgrade the presentation of results for the 2.5 version."
Seems like a bargain at a $61 premium.....As the test gains traction, I hope DNAP recognizes the true value and increases the price for future versions that have more bells and whistles. I understand they're walking a fine line when determining these price points!
All in all, I'm quite pleased with these PRs and hope they have shifted their bias to a more aggressive PR campaign. Maybe this is being orchestrated to create shareholder value (higher pps...) to limit the LJC shares?
News 
Market Data 
Discover 
